| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing belladonna alkaloid and phenobarbital (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Allergy to belladonna alkaloid |
Causative agent (attribute) |
False |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Allergy to belladonna alkaloid |
Causative agent (attribute) |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing belladonna alkaloids and ergotamine tartrate and phenobarbital |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing belladonna alkaloid and opium alkaloid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing belladonna alkaloid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Belladonna alkaloid-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aluminium hydroxide- and belladonna alkaloid-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Magnesium trisilicate+belladonna 0.15mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing belladonna alkaloid and magnesium trisilicate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing belladonna alkaloid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Belladonna alkaloid 16.2 mg and opium 30 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Belladonna alkaloid 16.2 mg and opium 60 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing belladonna alkaloid and secbutabarbital (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Belladonna alkaloid- and secbutabarbital-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing belladonna alkaloid and ergotamine and phenobarbital (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing belladonna alkaloid and ergotamine and phenobarbital in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Belladonna alkaloid 15 mg and secbutabarbital sodium 15 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Belladonna alkaloid 15 mg and secbutabarbital sodium 15 mg oral tablet |
Has precise active ingredient |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Levorotatory alkaloids of belladonna |
Is a |
False |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing only aluminium hydroxide and belladonna alkaloid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only belladonna alkaloid and ergotamine and phenobarbital (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Belladonna alkaloid and magnesium trisilicate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Belladonna alkaloid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only belladonna alkaloid and opium alkaloid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only belladonna alkaloid and phenobarbital (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Belladonna alkaloid and secbutabarbital only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only belladonna alkaloid in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only belladonna alkaloid and ergotamine and phenobarbital in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Belladonna alkaloid and secbutabarbital only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Belladonna alkaloid only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Belladonna alkaloid 16.2 mg and opium 60 mg rectal suppository |
Has precise active ingredient |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Belladonna alkaloid 16.2 mg and opium 60 mg rectal suppository |
Has basis of strength substance (attribute) |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Belladonna alkaloid- and opium-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Belladonna alkaloid 16.2 mg and opium 30 mg rectal suppository |
Has basis of strength substance (attribute) |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Belladonna alkaloid 16.2 mg and opium 30 mg rectal suppository |
Has precise active ingredient |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only belladonna alkaloid and opium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only belladonna alkaloid and opium in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing belladonna alkaloid and opium in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Belladonna alkaloids adverse reaction (disorder) |
Causative agent (attribute) |
True |
Belladonna alkaloids - chemical (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]